Stockreport

Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes

Lineage Cell Therapeutics, Inc.  (LCTX) 
PDF Initial Program Focus Will Be On Addressing Manufacturing Scale CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a c [Read more]